JAMA Network: Published on June, 2022Montelukast, the most widely used leukotriene-modifying agent (LTMA), is a selective leukotriene receptor antagonist and is currently indicated for prophylactic and chronic treatment of asthma, relief of symptoms of allergic rhinitis, and acute prevention of exercise-induced bronchoconstriction.This propensi...

TAKE-HOME MESSAGEVernal keratoconjunctivitis is a chronic, seasonally exacerbated, allergic inflammation of the eye.This prospective study evaluated the efficacy and safety of montelukast in conjunction with typical topical therapies for treating pediatric vernal keratoconjunctivitis (VKC). Patients were evaluated for subjective improvement in...

Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). It is also used before exercise to prevent breathing problems during exercise (bronchospasm).Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose).  Common Ast...